Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Royal Emerald Pharmaceuticals
company
About
Royal Emerald Pharmaceuticals produces non-addictive alternate medicines for dilemmas of PTSD and other health consequences.
- 251 - 500
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $16.97M
- Industries
- Alternative Medicine,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$16.97M
Royal Emerald Pharmaceuticals has raised a total of
$16.97M
in funding over 2 rounds. Their latest funding was raised on
Mar 8, 2022 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2022 | Debt Financing | $16.97M | 1 |
Pelorus Equity Group
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Royal Emerald Pharmaceuticals is funded by 1 investors.
Pelorus Equity Group
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Pelorus Equity Group
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
